Retina Forum 2022: Focus on Surgical Approaches and Therapeutics that Extend Treatment Intervals in nAMD and DME

Contact Us

Vindico Medical Education
6900 Grove Road
Thorofare, NJ 08086

Email Us

These continuing medical education activities are provided by

These activities are supported by an educational grant from Genentech, Inc., a member of the Roche Group.

CME Webinar Series

Series Overview

Pinnacle clinical trials in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) have demonstrated significant visual and anatomical improvements through treatment with anti-vascular endothelial growth factor (VEGF) therapies. Corticosteroid therapy is also an effective option for DME but is often not effectively integrated into treatment protocols. Improvements in visual and anatomical outcomes with real-world application of anti-VEGF therapies do not always align with those seen in pinnacle studies due to treatment burden and incomplete responses to therapy. To address these inconsistences in outcomes, treatment protocols using FDA-approved therapies continue to be refined, whereas novel delivery systems, gene therapies, and agents with unique mechanisms of action seek to address treatment burden through extending dosing intervals. In this CME series, experts in the field examine the current need for treatments that reduce the burden of frequent anti-VEGF injections for the management of nAMD and DME, assess approved therapies based upon their efficacy and safety in clinical studies, review the evidence about new and emerging surgical delivery systems that reduce treatment burden, and provide best practices that can reduce the potential for complications when implanting and refilling the Port Delivery System with ranibizumab.

Target Audience

The intended audience for this activity is ophthalmologists, retina specialists, and other health care professionals involved in the management of patients with nAMD and DME.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Examine the current need for treatments that reduce the burden of frequent anti-VEGF injections for the management of nAMD and DME. Compare the mechanisms of action of therapeutics that serve to lengthen the time between treatments for patients with nAMD or DME. Differentiate therapeutics for nAMD and DME based upon their efficacy and safety achieved in clinical trials. Assess evidence about new and emerging surgical delivery systems that reduce the need for frequent anti-VEGF injections in patients with nAMD or DME. Detail surgical procedures and techniques that can reduce the potential for complications when implanting and refilling the Port Delivery System with ranibizumab.

For more session-specific information, please visit the registration sites.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

856.994.9400 | 6900 Grove Road, Building 100 | Thorofare, New Jersey 08086

A Wyanoke Group Company

TAGS:Surgical on and Approaches

<<< Thank you for your visit >>>

Websites to related :
JMManion.com - Official Photogra

　　'); if (imageType == "swf"){newWindow.document.write('');newWindow.document.write('');newWindow.document.write('');newWindow.document.write('');}else{

Structural Steel Fabrication, Ma

　　HomeServices & Divisions Structural Steel DivisionRebar Division Steel Service Center DivisionEm-Co Metal Products, Inc: Str

Accueil | Concept Acier

　　 Cliquez ici

Beauce Atlas | Steel Structures.

　　 About usValuesWho we areCapacityCareerLeadersContactFrançais Complete ControlServ

Braces & Invisalign - San Jose,

　　 Freeman Orthodontics | Amazing experiences that are more than just great smiles. See What We mean The Freeman Team | A smart, compassionate,

Home - Warren Gibson Transport

PACENation - Property Assessed C

　　Skip links Skip to primary navigation Skip to content.ld_header_social_icons_631a58cc311fa.social-icon{font-size:17px;}.ld_header_social_icons_631a58c

Williamson Automotive Offers Aut

　　OUR SHOPLOCATIONPROMOTIONSCQ SPECIALSAUTO PARTSAUTO PARTS SERVICESGUARANTEESPARTS & REPAIR TIPSCONTACT USGENERAL MAINTENANCETRADE IN A GAS GUZZLERONLI

Okanagan Nation Alliance –

　　Skip to content ałi kwu_swiwi-numtax, ałi kwu_suknaqinx, ałi axa/ L/tmxwula/xw. We Are Beautiful,

AdCentives | Promotional Product

　　 HomeWho We AreAbout AdCentivesWhy Choose AdCentives?Logoed StuffOur MissionTestimonialsWhat We DoOur Ser

ads

Hot Websites

WHY YOU SHOULD Be listed

Matt Cutts, a software engineer and former head of the web spam team at Google, stated back in 2012 that "spammy directories" are disregarded while those who "excercise editorial discretion" worth it. Even though countless business directories litter the internet, they won't all offer a positive change. Don't take unneeded risks and suggest your website to one that Google loves!

Email: liunxqq$$$126.com ($$$=@) ie websites |